Aránzazu Mediero Selected Research

Aránzazu Mediero Research Topics

Disease

8	Inflammation (Inflammations) 11/2022 - 05/2012
6	Osteolysis 10/2021 - 05/2012
3	Osteoarthritis 11/2022 - 01/2017
3	Bone Resorption 01/2019 - 02/2012
3	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2005 - 01/2004
2	Knee Osteoarthritis 11/2022 - 01/2017
2	Rheumatoid Arthritis 12/2021 - 07/2013
2	Neoplasms (Cancer) 01/2016 - 02/2013
2	Glaucoma 05/2009 - 01/2004
2	Eye Diseases (Eye Disease) 01/2004 - 04/2003
1	Synovitis 11/2022
1	Ellis-Van Creveld Syndrome (Chondroectodermal Dysplasia) 01/2022
1	Hypertrophy 01/2022
1	Joint Diseases (Joint Disease) 12/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2021
1	Infections 07/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Obesity 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2016
1	Arthritis (Polyarthritis) 11/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Hyperplasia 01/2016
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2016
1	Fibrosis (Cirrhosis) 02/2014
1	Cicatrix (Scar) 12/2013
1	Fatigue 02/2013
1	Necrosis 02/2013
1	Prosthesis Failure 05/2012
1	Hypoxia (Hypoxemia) 02/2012
1	Wounds and Injuries (Trauma) 06/2009
1	Ocular Hypertension (Glaucoma, Suspect) 05/2009
1	Retinal Detachment (Retinal Detachments) 07/2005
1	Epiretinal Membrane (Epiretinal Membranes) 07/2004

Drug/Important Bio-Agent (IBA)

10	Adenosine (Adenocard)FDA LinkGeneric 10/2021 - 02/2012
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
5	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019 - 05/2012
3	Pharmaceutical PreparationsIBA 11/2022 - 02/2013
3	Tenofovir (Viread)FDA Link 10/2021 - 01/2019
3	CollagenIBA 01/2016 - 12/2013
2	LigandsIBA 11/2022 - 02/2012
2	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2018 - 05/2012
2	Netrin-1IBA 11/2016 - 01/2016
2	Monoclonal AntibodiesIBA 11/2016 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 03/2015 - 02/2013
2	Small Interfering RNA (siRNA)IBA 06/2009 - 05/2009
2	Atrial Natriuretic Factor (ANF)IBA 03/2005 - 07/2004
2	Natriuretic PeptidesIBA 03/2005 - 01/2004
2	ParaffinIBA 01/2004 - 04/2003
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2022
1	shogaolIBA 11/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	ConnexinsIBA 12/2021
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Polymethyl Methacrylate (Sol)IBA 07/2020
1	Adenosine DeaminaseIBA 05/2020
1	EnzymesIBA 05/2020
1	Inosine FDA Link 05/2020
1	NucleosidesIBA 05/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2019
1	Neuropilin-1IBA 01/2018
1	CD100 antigenIBA 01/2018
1	Semaphorin-3AIBA 01/2018
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2017
1	Sulfates (Sulfates, Inorganic)IBA 01/2017
1	Glucosamine (Dona)IBA 01/2017
1	Laminin (Merosin)IBA 11/2016
1	AntibodiesIBA 11/2016
1	Polyethylene (Polythene)IBA 01/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 09/2015
1	Phosphodiesterase 4 InhibitorsIBA 09/2015
1	apremilastIBA 09/2015
1	ZM 241385 (ZM241385)IBA 03/2015
1	CLOCK ProteinsIBA 02/2013
1	Cathepsin KIBA 05/2012
1	RANK LigandIBA 05/2012
1	OsteopontinIBA 05/2012
1	Tartrate-Resistant Acid PhosphataseIBA 02/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2012
1	diadenosine tetraphosphateIBA 06/2009
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2009
1	NucleotidesIBA 05/2009
1	ParasympathomimeticsIBA 05/2009
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2009
1	Peptides (Polypeptides)IBA 03/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2004

Therapy/Procedure

2	Therapeutics 06/2021 - 01/2017
2	Arthroplasty 07/2020 - 03/2015
1	Intraperitoneal Injections 11/2016
1	Prosthesis Implantation 01/2016
1	Radiotherapy 01/2016
1	Prostheses and Implants (Prosthesis) 01/2016
1	Ligation 03/2015
1	Reoperation 05/2012
1	Aftercare (After-Treatment) 05/2012
1	Vitrectomy 07/2005